CoChat

Glial adenosine kinase – A neuropathological marker of the epileptic brain

Open access
Aronica, Eleonora, Sandau, Ursula S., Iyer, Anand, Boison, Detlev · 2013 · Neurochemistry International
Cited by 70

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Experimental research over the past decade has supported the critical role of astrocytes activated by different types of injury and the pathophysiological processes that underlie the development of epilepsy. In both experimental and human epileptic tissues astrocytes undergo complex changes in their physiological properties, which can alter glio-neuronal communication, contributing to seizure precipitation and recurrence. In this context, understanding which of the molecular mechanisms are crucially involved in the regulation of glio-neuronal interactions under pathological conditions associated with seizure development is important to get more insight into the role of astrocytes in epilepsy. This article reviews current knowledge regarding the role of glial adenosine kinase as a neuropathological marker of the epileptic brain. Both experimental findings in clinically relevant models, as well as observations in drug-resistant human epilepsies will be discussed, highlighting the link between astrogliosis, dysfunction of adenosine homeostasis and seizure generation and therefore suggesting new strategies for targeting astrocyte-mediated epileptogenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuint.2013.01.028

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Astrocytes: Biology and pathology

    Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196 · cited 2×

    “Expression of ADK in the epileptic brain Astrogliosis is a pathological hallmark of various types of medically refractory focal epilepsy, including epilepsy that develops following traumatic, ischemic or infectious brain injury (Sofroniew and Vinters, 2010).”
    Background
  • Adenosine Receptors as Therapeutic Targets

    Jacobson, K. A., & Gao, Z.-G. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1983 · Cited by 1,431 · cited 1×

    “As a result, systemic administration of A1R agonists or ADK inhibitors successfully attenuates seizure activity (Fredholm, 2003; Jacobson and Gao, 2006; Boison, 2011).”
    Background
  • Astrocytic Purinergic Signaling Coordinates Synaptic Networks

    Pascual, O., Casper, K. B., Kubera, C., Zhang, J., Revilla-Sanchez, R., Sul, J.-Y., Takano, H., Moss, S. J., McCarthy, K., & Haydon, P. G. (2005) · Science · doi:10.1126/science.1116916 · Cited by 1,280 · cited 1×

    “In regards to astrocytes, high frequency stimulation of the CA1 pyramidal neurons induces a Ca2+ mediated release of ATP from astrocytes (Cotrina et al., 1998; Zhang et al., 2003; Pascual et al., 2005) through either vesicular transport (Pascual et al., 2005) or hemichannels (Kang et al., 2008).”
    Background
  • In-vivo measurement of activated microglia in dementia

    Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054 · cited 1×

    “…an increase in astrogliosis, as observed across multiple disease processes including epilepsy (Sofroniew and Vinters, 2010) and Alzheimer’s disease (Cagnin et al., 2001; Nagele et al., 2004), has profound effects on extracellular adenosine levels and adenosine mediated signalling (Boison, 2008).”
    Background
  • Epilepsy and Cognitive Impairments in Alzheimer Disease

    Palop, J. J. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.15 · Cited by 684 · cited 1×

    “In addition, it could be interesting to take into consideration the potential role of focal deregulation of ADK expression/ function in reactive astrocytes within the context of epilepsy associated with Alzheimer disease (AD) (Palop and Mucke, 2009; Roberson, 2011).”
    Background
  • Adenosine receptors and brain diseases: neuroprotection and neurodegeneration

    Gomes, C. V., Kaster, M. P., Tomé, A. R., Agostinho, P. M., & Cunha, R. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.001 · Cited by 419 · cited 2×

    “Increasing evidence points towards a critical role of ARs in neuron-glia communication and neuroinflammation (Boison, 2010; Gomes et al., 2011).”
    Background
  • Potential New Antiepileptogenic Targets Indicated by Microarray Analysis in a Rat Model for Temporal Lobe Epilepsy

    Gorter, J. A., van Vliet, E. A., Aronica, E., Breit, T., Rauwerda, H., Lopes da Silva, F. H., & Wadman, W. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2766-06.2006 · Cited by 316

    Self-citation
  • Inflammation in epilepsy: Clinical observations

    Aronica, E., & Crino, P. B. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03033.x · Cited by 306 · cited 1×

    “Inflammatory molecules, such as IL-1β, upregulated in epileptogenic tissue from TLE patients [for review see (Aronica and Crino, 2011; Vezzani et al., 2011)] may also play a role in the regulation of adenosine cycle in astrocytes.”
    BackgroundSelf-citation
  • Long‐Term Epilepsy‐Associated Tumors

    Thom, M., Blümcke, I., & Aronica, E. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00582.x · Cited by 231 · cited 1×

    “Additional studies of a series of tumors, including a large cohort of long-term epilepsy associated tumors [LEAT; (Thom et al., 2012)], which could be stratified on the basis of the duration and/or severity of epilepsy, are essential to further assess the value of ADK expression/activity as a…”
    BackgroundSelf-citation

Cited by

See all 70

Metadata

Authors
Aronica, E., Sandau, U. S., Iyer, A., & Boison, D.
Venue
Neurochemistry International
Publisher
Elsevier BV
Published
2013-12
Volume
63
Issue
7
Pages
688-695
ISSN
0197-0186 (ISSN-L)
OpenAlex
W2168886236
Cited by
70
References
9
FWCI
4.89
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.